Related Experiment Videos
Matrix metalloproteinases
S L Parsons1, S A Watson, P D Brown
1Department of Surgery, University Hospital, Nottingham, UK.
Background:
The matrix metalloproteinases (MMPs) have a role in gastrointestinal malignancy. This role is reviewed, with particular reference to the gelatinase subgroup of enzymes.
Methods:
All relevant papers derived from the Medline and Enbase databases between 1984 and early 1996 were reviewed.
Result And Conclusion:
There is now strong evidence that MMPs play a major role in tumour invasion and metastasis. The development of MMP inhibitors may lead to important new treatment for the control of malignant disease.
Insights
Matrix metalloproteinases (MMPs) are crucial in gastrointestinal cancer progression. Inhibiting these enzymes shows promise for new anti-cancer therapies targeting tumor invasion and metastasis.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Matrix metalloproteinases (MMPs) are implicated in the development of gastrointestinal malignancy.
- This review focuses on the role of MMPs, particularly the gelatinase subgroup, in cancer.
Purpose of the Study:
- To review the role of matrix metalloproteinases (MMPs) in gastrointestinal malignancy.
- To highlight the significance of gelatinase subgroup enzymes.
Main Methods:
- A comprehensive literature review was conducted.
- Papers were sourced from Medline and Enbase databases, covering the period from 1984 to early 1996.
Main Results:
- MMPs play a significant role in tumor invasion and metastasis.
- Evidence strongly supports the involvement of MMPs in cancer spread.
Conclusions:
- MMP inhibitors represent a potential therapeutic strategy for managing malignant diseases.
- Targeting MMPs could offer new avenues for cancer treatment, particularly for controlling invasion and metastasis.